20 June 2013
Keywords: sosei, files, maa, cancer, drug, sot-375, tokyo
Article | 07 March 2005
Tokyo, Japan-based Sosei says it has submitted a Marketing Authorization Application for SOT-375 (leuprolide acetate) to the
Japanese Ministry of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 March 2005
28 February 2005
19 June 2013
© 2013 thepharmaletter.com